Mostrando 4 resultados de: 4
Filtros aplicados
Publisher
Health and Quality of Life Outcomes(2)
BMC research notes(1)
Clinical and Applied Thrombosis/Hemostasis(1)
Área temáticas
Enfermedades(4)
Medicina y salud(4)
Problemas sociales y servicios a grupos(2)
Dirección general(1)
Farmacología y terapéutica(1)
Origen
scopus(4)
Clinical interval and diagnostic characteristics in a cohort of bladder cancer patients in Spain: a multicenter observational study
ArticleAbstract: OBJECTIVE: We performed a cohort study in seven hospitals in Spain to determine the clinical charactPalabras claves:Diagnostic techniques and procedures, Neoplasm staging, Observational Study, Time factors, Urinary bladder neoplasmAutores:Abraira V., Bonfill X., De la Cruz J., Emparanza J.I., Ferrer M., Ma José Martínez Zapata, Madrid E., Palou J., Pijoan Zubizarreta J.I., Sánchez M.J., Schmidt S., Suarez-Varela M.M.M., Vernooij R.W.M., Zamora J.Fuentes:scopusBladder cancer index: Cross-cultural adaptation into Spanish and psychometric evaluation
ArticleAbstract: Background: The Bladder Cancer Index (BCI) is so far the only instrument applicable across all bladdPalabras claves:Patient outcomes, psychometrics, quality of life, urinary bladder neoplasms, validation studiesAutores:Abraira V., Algaba F., Alonso J., Bachs J., Ballester F.S., Bastida J.L., Becerra V., Bolívar I., Bonfill X., Burgos J., Cabeza Rodríguez M.A., Camps C., Canovas E., Castro Diaz D.M., Cebollada M.M., Chan D.C., Cosp X.B., Cózar-Olmo J.M., de la Cámara A.G., De la Cruz J., dela Cruz J., Díaz C.C., Díaz I.R., Díaz Moratinos A.I., Dimelza Osorio, Dos Santos V.G., Emparanza J.I., Esquena S., Farras N.P., Ferrer M., Fores M.F., Francés A., Garcia A.M., Garcia S.S., Garin O., Goñi J.M.R., González A.L., Hervás A., Jimenez Cidre M.A., Juan Escudero J.U., López C.G., Lopez R.M., López-Fando Lavalle L., Lorente C.M., Lorente Garin J.A., Luis A.M., Ma José Martínez Zapata, Maroto J.P., Martínez A., Martínez C., Martinez J.P., Martínez L., Morales M., Morales-Suarez-Varela M.M., Muñoz H.G., Ocaña C.V., Pacheco A.S., Pardo G.S., Pardo Y., Peidro J.P., Pijoan Zubizarreta J.I., Polo Rubio J.A., Puigvert F., Quintana M.J., Ramos Campos M.M., Redorta P., Riel R., Sánchez M.J., Sanchez Perez M.J., Sanz Jaka J.P., Schmidt S., Suñol R., Torrecilla J.L., Varona C., Velásquez M.J., Vernooij R.W.M., Vidal E.M., Villagran C.O., Zamora J.Fuentes:scopusIntensive follow-up for women with breast cancer: Review of clinical, economic and patient's preference domains through evidence to decision framework
ArticleAbstract: Background: Women treated for breast cancer are followed-up for monitoring of treatment effectivenesPalabras claves:Breast Cancer, EtD framework, follow-up, RecommendationAutores:Alonso-Coello P., Bramesfeld A., Deandrea S., Lafranconi A., Lerda D., Ma José Martínez Zapata, Neamtiu L., Posso M., Pylkkänen L., Rigau D., Saz-Parkinson Z.Fuentes:scopusTinzaparin for Long-Term Treatment of Venous Thromboembolism in Patients With Cancer: A Systematic Review and Meta-Analysis
ReviewAbstract: Patients with cancer are at increased risk of recurrent venous thromboembolism (VTE) and bleeding. TPalabras claves:Anticoagulant, malignancy, tinzaparin, Venous thromboembolismAutores:Bauersachs R., Ma José Martínez Zapata, Mathioudakis A.G., Mousa S.A.Fuentes:scopus